31.07.2013 • NewsAndrew LiverisDede WillamsDow Chemical

Dow Chemical EBITDA up 9% in Q2

U.S. chemical giant Dow Chemical saw adjusted EBITDA gain nearly 9% year-on-year to $ 2.1 billion in Q2 2013, thanks mainly to strong business in the Agricultural Science and Performance Plastics segments. The unusually large adjustment reflects a payment of $2.2 from Petrochemical Industries Company of Kuwait in arbitration over the K-Dow joint venture canceled by Kuwait in 2009. Quarterly sales were flat at $14.6 billion. Led by activities in emerging markets that more than offset a decline in Europe, volume growth averaged 9%, said CEO Andrew Liveris. Prices receded by 2%, due in part to currency translations. 

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.